The Nigerian Content Development and Monitoring Board (NCDMB) and Nigeria Liquefied Natural Gas (NLNG) Limited have ...

Oral FASN inhibitors offer a novel mechanism of action for the potential treatment of moderate to severe acne Sagimet initiated first-in-human Phase 1 clinical trial of a second FASN inhibitor, ...

We think Dayforce is in an acceptable financial position. With $557 million on the balance sheet and $582 million in short-term debt as of first-quarter 2025, the company is likely to refinance in the ...

NEW YORK--(BUSINESS WIRE)--Volastra Therapeutics, a clinical-stage cancer biotechnology company focused on chromosomal instability, today announced preliminary safety and efficacy data from its ...

Both assets are currently being evaluated in Phase 1 clinical trials ... ARCH Ventures, B-Capital, Droia Ventures, Vida Ventures, Catalio Capital Management and Eli Lilly & Company.

This Best Places to Work 2025 winner provides one-on-one executive coaching. © 2025 American City Business Journals. All rights reserved. Use of and/or registration ...

human capital, and growth in a system of equations. The paper finds that both education and health spending have a positive and significant direct impact on the accumulation of education and health ...

Capital includes not only financial resources but also human capital – the employees who bring skills and value to a company. Understanding capital management in business The role of human capital ...

Nearly 16 months after the high-profile deal was first announced, Capital One and Discover officially merged Sunday, combining to become the sixth-largest U.S. bank by asset size. “This deal ...

Capital One says customers shouldn't expect any immediate changes to accounts following its merger with Discover. In the coming months, Capital One account holders may get cashback debit cards and ...